Polio vaccine development in Canada: Contributions to global polio eradication

被引：4
作者：
Barreto, L
Van Exan, R
Rutty, CJ
机构：
[1] Sanofi Pasteur Ltd, Toronto, ON M2R 3T4, Canada
[2] Hlth Heritage Res Serv, Toronto, ON, Canada
来源：
BIOLOGICALS | 2006年 / 34卷 / 02期
关键词：
polio epidemic; Salk vaccine; Sabin vaccine; Connaught laboratories; global polio eradication; Canada;
D O I：
10.1016/j.biologicals.2006.03.008
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The paper briefly describes Canada's distinctive experience in the control of polio and offers some lessons for governments and health policy leaders in other jurisdictions, particularly as they consider immunization policies for the post-polio-eradication era. (c) 2006 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：91 / 101
页数：11
相关论文
共 104 条
[1]  
[Anonymous], 1995, THESIS U TORONTO
[2]  
ARMSTRON A, 1937, SATURDAY NIGHT 1009, P2
[3]  
BATOR P, 1990, REACH EVERYONE HIST, V1, P1927
[4]  
BATOR PA, 1995, REACH HIST U TORONTO, V2, P1955
[5]  
Berk L B, 1989, Trans Stud Coll Physicians Phila, V11, P321
[6]  
BROWN W G, 1958, Can Med Assoc J, V79, P155
[7]  
CADHAM RG, 1954, POLIOMYELITIS EPIDMI, V45, P185
[8]  
CAMERON, 1953, COMMUNICATION 1123
[9]  
CAMERON, 1953, COMMUNICATION 1208
[10]  
*CMRL, 1960, ANN REP, P4
12345678910